Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 263

1.

Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival.

Ward SV, Gibbs DC, Orlow I, Thomas NE, Kanetsky PA, Luo L, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Rosso S, Zanetti R, Dwyer T, Begg CB, Berwick M; GEM Study Group.

Br J Dermatol. 2020 Jan 20. doi: 10.1111/bjd.18881. [Epub ahead of print] No abstract available.

PMID:
31958143
2.

Inherited Melanoma Risk Variants Associated with Histopathologically Amelanotic Melanoma.

Gibbs DC, Orlow I, Vernali S, Powell HB, Kanetsky PA, Luo L, Busam KJ, Sharma A, Kricker A, Armstrong BK, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

J Invest Dermatol. 2019 Sep 27. pii: S0022-202X(19)33239-7. doi: 10.1016/j.jid.2019.09.006. [Epub ahead of print] No abstract available.

PMID:
31568773
3.

A risk prediction model for the development of subsequent primary melanoma in a population-based cohort.

Cust AE, Badcock C, Smith J, Thomas NE, Haydu LE, Armstrong BK, Law MH, Thompson JF, Kanetsky PA, Begg CB, Shi Y, Kricker A, Orlow I, Sharma A, Yoo S, Leong SF, Berwick M, Ollila DW, Lo S.

Br J Dermatol. 2019 Sep 14. doi: 10.1111/bjd.18524. [Epub ahead of print]

PMID:
31520533
4.

The Role of Ceramide 1-Phosphate in Inflammation, Cellular Proliferation, and Wound Healing.

Berwick ML, Dudley BA, Maus K, Chalfant CE.

Adv Exp Med Biol. 2019;1159:65-77. doi: 10.1007/978-3-030-21162-2_5. Review.

PMID:
31502200
5.

MC1R Variation in a New Mexico Population.

White KAM, Dailey YT, Guest DD, Zielaskowski K, Robers E, Sussman A, Hunley K, Hughes CR, Schwartz MR, Kaphingst KA, Buller DB, Hay JL, Berwick M.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1853-1856. doi: 10.1158/1055-9965.EPI-19-0378. Epub 2019 Sep 5.

PMID:
31488411
6.

Psychosocial and Cultural Determinants of Interest and Uptake of Skin Cancer Genetic Testing in Diverse Primary Care.

Hay JL, Meyer White K, Sussman A, Kaphingst K, Guest D, Schofield E, Dailey YT, Robers E, Schwartz MR, Zielaskowski K, Li Y, Buller D, Hunley K, Berwick M.

Public Health Genomics. 2019;22(1-2):58-68. doi: 10.1159/000501985. Epub 2019 Aug 22.

7.

MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.

Pellegrini C, Botta F, Massi D, Martorelli C, Facchetti F, Gandini S, Maisonneuve P, Avril MF, Demenais F, Bressac-de Paillerets B, Hoiom V, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Marrett L, Zanetti R, Dwyer T, Thomas NE, Begg CB, Berwick M, Puig S, Potrony M, Nagore E, Ghiorzo P, Menin C, Manganoni AM, Rodolfo M, Brugnara S, Passoni E, Sekulovic LK, Baldini F, Guida G, Stratigos A, Ozdemir F, Ayala F, Fernandez-de-Misa R, Quaglino P, Ribas G, Romanini A, Migliano E, Stanganelli I, Kanetsky PA, Pizzichetta MA, García-Borrón JC, Nan H, Landi MT, Little J, Newton-Bishop J, Sera F, Fargnoli MC, Raimondi S; IMI Study Group; GEM Study Group; M-SKIP Study Group.

Lancet Child Adolesc Health. 2019 May;3(5):332-342. doi: 10.1016/S2352-4642(19)30005-7. Epub 2019 Mar 12.

PMID:
30872112
8.

Histopathologic variables differentially affect melanoma survival by age at diagnosis.

Mishra K, Barnhill RL, Paddock LE, Fine JA, Berwick M.

Pigment Cell Melanoma Res. 2019 Jul;32(4):593-600. doi: 10.1111/pcmr.12770. Epub 2019 Feb 16.

PMID:
30706692
9.

Relationship of Chromosome Arm 10q Variants to Occurrence of Multiple Primary Melanoma in the Population-Based Genes, Environment, and Melanoma (GEM) Study.

Miles JA, Orlow I, Kanetsky PA, Luo L, Cust AE, Armstrong BK, Kricker A, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Gibbs DC, Busam KJ, Mavinkurve V, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

J Invest Dermatol. 2019 Jun;139(6):1410-1412. doi: 10.1016/j.jid.2018.11.030. Epub 2018 Dec 17. No abstract available.

PMID:
30571972
10.

Trajectories of Nevus Development From Age 3 to 16 Years in the Colorado Kids Sun Care Program Cohort.

Asdigian NL, Barón AE, Morelli JG, Mokrohisky ST, Aalborg J, Dellavalle RP, Daley MF, Berwick M, Muller KE, Box NF, Crane LA.

JAMA Dermatol. 2018 Nov 1;154(11):1272-1280. doi: 10.1001/jamadermatol.2018.3027.

11.

A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.

Zhao Y, Schaafsma E, Gorlov IP, Hernando E, Thomas NE, Shen R, Turk MJ, Berwick M, Amos CI, Cheng C.

Mol Cancer Res. 2019 Jan;17(1):109-119. doi: 10.1158/1541-7786.MCR-18-0173. Epub 2018 Aug 31.

12.

Melanoma - role of the environment and genetics.

Cust AE, Mishra K, Berwick M.

Photochem Photobiol Sci. 2018 Dec 5;17(12):1853-1860. doi: 10.1039/c7pp00411g. Review.

PMID:
30113042
13.

Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics.

Gorlov I, Orlow I, Ringelberg C, Hernando E, Ernstoff MS, Cheng C, Her S, Parker JS, Thompson CL, Gerstenblith MR, Berwick M, Amos C.

Melanoma Res. 2018 Oct;28(5):380-389. doi: 10.1097/CMR.0000000000000473.

14.

Application of mutagen sensitivity assay in a glioma case-control study.

Erdal S, McCarthy BJ, Gurule N, Berwick M, Gonzales E, Byrd J, Flores K, Shimek J, Il'yasova D, Ali-Osman F, Bigner DD, Davis FG, Leyba AN, White KAM.

Toxicol Rep. 2018 Jan 9;5:183-188. doi: 10.1016/j.toxrep.2017.12.010. eCollection 2018.

15.

Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.

Hay JL, Zielaskowski K, Meyer White K, Kaphingst K, Robers E, Guest D, Sussman A, Talamantes Y, Schwartz M, Rodríguez VM, Li Y, Schofield E, Bigney J, Hunley K, Buller D, Berwick M.

JAMA Dermatol. 2018 Jun 1;154(6):684-693. doi: 10.1001/jamadermatol.2018.0592.

16.

Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.

Thomas NE, Edmiston SN, Orlow I, Kanetsky PA, Luo L, Gibbs DC, Parrish EA, Hao H, Busam KJ, Armstrong BK, Kricker A, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group.

J Invest Dermatol. 2018 Nov;138(11):2398-2404. doi: 10.1016/j.jid.2018.04.025. Epub 2018 May 9.

17.

Editorial: When Is Correlation Causation?

Berwick M.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx087. No abstract available.

PMID:
29117386
18.

The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival.

Orlow I, Shi Y, Kanetsky PA, Thomas NE, Luo L, Corrales-Guerrero S, Cust AE, Sacchetto L, Zanetti R, Rosso S, Armstrong BK, Dwyer T, Venn A, Gallagher RP, Gruber SB, Marrett LD, Anton-Culver H, Busam K, Begg CB, Berwick M; GEM Study Group.

Pigment Cell Melanoma Res. 2018 Mar;31(2):287-296. doi: 10.1111/pcmr.12653. Epub 2017 Nov 5.

19.

Social-group identity and population substructure in admixed populations in New Mexico and Latin America.

Healy ME, Hill D, Berwick M, Edgar H, Gross J, Hunley K.

PLoS One. 2017 Oct 4;12(10):e0185503. doi: 10.1371/journal.pone.0185503. eCollection 2017.

20.

Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.

Thomas NE, Edmiston SN, Kanetsky PA, Busam KJ, Kricker A, Armstrong BK, Cust AE, Anton-Culver H, Gruber SB, Luo L, Orlow I, Reiner AS, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Parrish EA, Hao H, Gibbs DC, Frank JS, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group.

J Invest Dermatol. 2017 Dec;137(12):2588-2598. doi: 10.1016/j.jid.2017.07.832. Epub 2017 Aug 24.

21.

Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.

Vernali S, Waxweiler WT, Dillon PM, Kanetsky PA, Orlow I, Luo L, Busam KJ, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

JAMA Dermatol. 2017 Oct 1;153(10):1026-1031. doi: 10.1001/jamadermatol.2017.2444.

22.

Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.

Gibbs DC, Ward SV, Orlow I, Cadby G, Kanetsky PA, Luo L, Busam KJ, Kricker A, Armstrong BK, Cust AE, Anton-Culver H, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

Br J Dermatol. 2017 Nov;177(5):e180-e182. doi: 10.1111/bjd.15784. Epub 2017 Oct 6. No abstract available.

23.

Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma.

Mauguen A, Zabor EC, Thomas NE, Berwick M, Seshan VE, Begg CB.

J Am Stat Assoc. 2017;112(517):54-63. doi: 10.1080/01621459.2016.1191499. Epub 2017 May 3.

24.

Topical Delivery of Anti-VEGF Drugs to the Ocular Posterior Segment Using Cell-Penetrating Peptides.

de Cogan F, Hill LJ, Lynch A, Morgan-Warren PJ, Lechner J, Berwick MR, Peacock AFA, Chen M, Scott RAH, Xu H, Logan A.

Invest Ophthalmol Vis Sci. 2017 May 1;58(5):2578-2590. doi: 10.1167/iovs.16-20072.

PMID:
28494491
25.

Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled Trial.

Hay JL, Berwick M, Zielaskowski K, White KA, Rodríguez VM, Robers E, Guest DD, Sussman A, Talamantes Y, Schwartz MR, Greb J, Bigney J, Kaphingst KA, Hunley K, Buller DB.

JMIR Res Protoc. 2017 Apr 25;6(4):e52. doi: 10.2196/resprot.7158.

26.

No association between prediagnosis exercise and survival in patients with high-risk primary melanoma: A population-based study.

Schwitzer E, Orlow I, Zabor EC, Begg CB, Berwick M, Thomas NE, Kanetsky PA, Jones LW; GEM Study Group.

Pigment Cell Melanoma Res. 2017 Jul;30(4):424-427. doi: 10.1111/pcmr.12594. Epub 2017 Jun 8. No abstract available.

27.

No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival.

Luo L, Orlow I, Kanetsky PA, Thomas NE, Fang S, Lee JE, Berwick M, Lee JH; GEM Study Group.

PLoS One. 2017 Mar 21;12(3):e0174234. doi: 10.1371/journal.pone.0174234. eCollection 2017.

28.

Antimicrobial peptide coatings for hydroxyapatite: electrostatic and covalent attachment of antimicrobial peptides to surfaces.

Townsend L, Williams RL, Anuforom O, Berwick MR, Halstead F, Hughes E, Stamboulis A, Oppenheim B, Gough J, Grover L, Scott RA, Webber M, Peacock AF, Belli A, Logan A, de Cogan F.

J R Soc Interface. 2017 Jan;14(126). pii: 20160657. doi: 10.1098/rsif.2016.0657.

29.

Invited Commentary: Indoor Tanning-A Melanoma Accelerator?

Berwick M, Doré JF.

Am J Epidemiol. 2017 Feb 1;185(3):157-159. doi: 10.1093/aje/kww149.

30.

The risks and benefits of sun exposure 2016.

Hoel DG, Berwick M, de Gruijl FR, Holick MF.

Dermatoendocrinol. 2016 Oct 19;8(1):e1248325. eCollection 2016 Jan-Dec. Review.

31.

Translation and adaptation of skin cancer genomic risk education materials for implementation in primary care.

Rodríguez VM, Robers E, Zielaskowski K, Javier González C, Hunley K, Kaphingst KA, Guest DD, Sussman A, Meyer White KA, Schwartz MR, Greb J, Talamantes Y, Bigney J, Berwick M, Hay JL.

J Community Genet. 2017 Jan;8(1):53-63. doi: 10.1007/s12687-016-0287-z. Epub 2016 Dec 6.

32.

Communication about melanoma and risk reduction after melanoma diagnosis.

Rodríguez VM, Berwick M, Hay JL.

Psychooncology. 2017 Dec;26(12):2142-2148. doi: 10.1002/pon.4315. Epub 2016 Dec 6.

33.

Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study.

White KA, Luo L, Thompson TA, Torres S, Hu CA, Thomas NE, Lilyquist J, Anton-Culver H, Gruber SB, From L, Busam KJ, Orlow I, Kanetsky PA, Marrett LD, Gallagher RP, Sacchetto L, Rosso S, Dwyer T, Cust AE, Begg CB, Berwick M; GEM Study Group.

Cancer Med. 2016 Nov;5(11):3336-3345. doi: 10.1002/cam4.929. Epub 2016 Oct 17.

34.

Skin Cancer Risk Reduction Behaviors Among American Indian and Non-Hispanic White Persons in Rural New Mexico.

Logue ME, Hough T, Leyva Y, Kee J, Berwick M.

JAMA Dermatol. 2016 Dec 1;152(12):1382-1383. doi: 10.1001/jamadermatol.2016.3280. No abstract available.

PMID:
27626611
35.

Competing risks survival of older patients with metastatic cutaneous melanoma: a SEER population-based study.

Hoag JR, Hegde U, Zweifler R, Berwick M, Swede H.

Melanoma Res. 2016 Oct;26(5):505-12. doi: 10.1097/CMR.0000000000000276.

PMID:
27584045
36.

The study of nevi in children: Principles learned and implications for melanoma diagnosis.

Scope A, Marchetti MA, Marghoob AA, Dusza SW, Geller AC, Satagopan JM, Weinstock MA, Berwick M, Halpern AC.

J Am Acad Dermatol. 2016 Oct;75(4):813-823. doi: 10.1016/j.jaad.2016.03.027. Epub 2016 Jun 17. Review.

37.

Patterns and sources of information about family melanoma risk among melanoma survivors.

Zapolska J, Hay J, Li Y, Orlow I, Begg CB, Berwick M.

Melanoma Manag. 2016 Jun;3(2):105-111. doi: 10.2217/mmt-2015-0003. Epub 2016 May 19.

38.

Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma.

Taylor NJ, Thomas NE, Anton-Culver H, Armstrong BK, Begg CB, Busam KJ, Cust AE, Dwyer T, From L, Gallagher RP, Gruber SB, Nishri DE, Orlow I, Rosso S, Venn AJ, Zanetti R, Berwick M, Kanetsky PA; GEM Study Group.

Int J Cancer. 2016 Sep 15;139(6):1217-22. doi: 10.1002/ijc.30157. Epub 2016 May 30.

39.

Skin self-examination and long-term melanoma survival.

Paddock LE, Lu SE, Bandera EV, Rhoads GG, Fine J, Paine S, Barnhill R, Berwick M.

Melanoma Res. 2016 Aug;26(4):401-8. doi: 10.1097/CMR.0000000000000255.

PMID:
26990272
40.

Location dependent coordination chemistry and MRI relaxivity, in de novo designed lanthanide coiled coils.

Berwick MR, Slope LN, Smith CF, King SM, Newton SL, Gillis RB, Adams GG, Rowe AJ, Harding SE, Britton MM, Peacock AFA.

Chem Sci. 2016 Mar 1;7(3):2207-2216. doi: 10.1039/c5sc04101e. Epub 2015 Dec 22.

41.

Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

Gibbs DC, Orlow I, Bramson JI, Kanetsky PA, Luo L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Sharma A, La Pilla E, From L, Busam KJ, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

J Natl Cancer Inst. 2016 Feb 8;108(7). pii: djw004. doi: 10.1093/jnci/djw004. Print 2016 Jul.

42.

Association Between Indoor Tanning and Melanoma in Younger Men and Women.

Lazovich D, Isaksson Vogel R, Weinstock MA, Nelson HH, Ahmed RL, Berwick M.

JAMA Dermatol. 2016 Mar;152(3):268-75. doi: 10.1001/jamadermatol.2015.2938.

43.

Reply to S. Lehrer et al and J.C. Dowdy and R.M. Sayre.

Berwick M.

J Clin Oncol. 2016 Feb 20;34(6):638-9. doi: 10.1200/JCO.2015.64.9384. Epub 2016 Jan 4. No abstract available.

PMID:
26729438
44.

Melanoma Epidemiology and Prevention.

Berwick M, Buller DB, Cust A, Gallagher R, Lee TK, Meyskens F, Pandey S, Thomas NE, Veierød MB, Ward S.

Cancer Treat Res. 2016;167:17-49. doi: 10.1007/978-3-319-22539-5_2. Review.

PMID:
26601858
45.

Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study.

Orlow I, Reiner AS, Thomas NE, Roy P, Kanetsky PA, Luo L, Paine S, Armstrong BK, Kricker A, Marrett LD, Rosso S, Zanetti R, Gruber SB, Anton-Culver H, Gallagher RP, Dwyer T, Busam K, Begg CB, Berwick M; GEM Study Group.

Carcinogenesis. 2016 Jan;37(1):30-8. doi: 10.1093/carcin/bgv157. Epub 2015 Oct 31.

46.

Arsenic and ultraviolet radiation exposure: melanoma in a New Mexico non-Hispanic white population.

Yager JW, Erdei E, Myers O, Siegel M, Berwick M.

Environ Geochem Health. 2016 Jun;38(3):897-910. doi: 10.1007/s10653-015-9770-4. Epub 2015 Oct 7.

PMID:
26445994
47.

Alcohol consumption and risk of melanoma among women: pooled analysis of eight case-control studies.

Miura K, Zens MS, Peart T, Holly EA, Berwick M, Gallagher RP, Mack TM, Elwood JM, Karagas MR, Green AC.

Arch Dermatol Res. 2015 Nov;307(9):819-28. doi: 10.1007/s00403-015-1591-x. Epub 2015 Jul 16.

PMID:
26179744
48.

Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.

Thomas NE, Edmiston SN, Alexander A, Groben PA, Parrish E, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, From L, Busam KJ, Hao H, Orlow I, Kanetsky PA, Luo L, Reiner AS, Paine S, Frank JS, Bramson JI, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Cust AE, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group.

JAMA Oncol. 2015 Jun;1(3):359-68. Erratum in: JAMA Oncol. 2015 Jun;1(3):285.

49.

Dietary Advice for Melanoma: Not Ready for Prime Time.

Berwick M.

J Clin Oncol. 2015 Aug 10;33(23):2487-8. doi: 10.1200/JCO.2015.61.8116. Epub 2015 Jun 29. No abstract available.

PMID:
26124491
50.

Inherited genetic variants associated with occurrence of multiple primary melanoma.

Gibbs DC, Orlow I, Kanetsky PA, Luo L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Sharma A, La Pilla E, From L, Busam KJ, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):992-7. doi: 10.1158/1055-9965.EPI-14-1426. Epub 2015 Apr 2.

Supplemental Content

Loading ...
Support Center